Integra LifeSciences Announces Preliminary First Quarter Revenue Results and Provides an Update on COVID-19 Impact; Will Host First Quarter 2020 Financial Results Conference Call on May 7, 2020

NEXT STORY
Roche provides regulatory update on risdiplam for the treatment of spinal muscular atrophy (SMA)
PREV STORY
Letter to AB Science stakeholders on COVID-19 pandemic impact on AB Science clinical studies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

National Summer Learning Association Recognizes Four Exemplary Summer Programs Improving Outcomes for Children and Youth

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Proposed Public Offering of ADSs

COPENHAGEN, Denmark, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical ...

author_avatar
NASDAQ Market News

Immunoassay Market Worth $46.5 Billion by 2028, Growing at a CAGR of 7.5% From 2021- Exclusive Report by Meticulous Research®

author_avatar
NASDAQ Market News